Involvement of the platelet-activating factor receptor in host defense againstStreptococcus pneumoniaeduring postinfluenza pneumonia
- 1 January 2006
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Lung Cellular and Molecular Physiology
- Vol. 290 (1) , L194-L199
- https://doi.org/10.1152/ajplung.00050.2005
Abstract
Although influenza infection alone may lead to pneumonia, secondary bacterial infections are a much more common cause of pneumonia. Streptococcus pneumoniae is the most frequently isolated causative pathogen during postinfluenza pneumonia. Considering that S. pneumoniae utilizes the platelet-activating factor receptor (PAFR) to invade the respiratory epithelium and that the PAFR is upregulated during viral infection, we here used PAFR gene-deficient (PAFR−/−) mice to determine the role of this receptor during postinfluenza pneumococcal pneumonia. Viral clearance was similar in wild-type and PAFR−/− mice, and influenza virus was completely removed from the lungs at the time mice were inoculated with S. pneumoniae (day 14 after influenza infection). PAFR−/− mice displayed a significantly reduced bacterial outgrowth in their lungs, a diminished dissemination of the infection, and a prolonged survival. Pulmonary levels of IL-10 and KC were significantly lower in PAFR−/− mice, whereas IL-6 and TNF-α were only trendwise lower. These data indicate that the pneumococcus uses the PAFR leading to severe pneumonia in a host previously exposed to influenza A.Keywords
This publication has 30 references indexed in Scilit:
- Improved Host Defense against Pneumococcal Pneumonia in Platelet‐Activating Factor Receptor–Deficient MiceThe Journal of Infectious Diseases, 2004
- Role of the platelet‐activating factor (PAF) receptor during pulmonary infection with gram negative bacteriaBritish Journal of Pharmacology, 2002
- Lethal Synergism between Influenza Virus andStreptococcus pneumoniae:Characterization of a Mouse Model and the Role of Platelet‐Activating Factor ReceptorThe Journal of Infectious Diseases, 2002
- CXC Chemokine Redundancy Ensures Local Neutrophil Recruitment during Acute InflammationThe American Journal of Pathology, 2001
- Microbiological and Inflammatory Factors Associated with the Development of Pneumococcal PneumoniaThe Journal of Infectious Diseases, 2001
- Simultaneous Detection of Influenza Viruses A and B Using Real-Time Quantitative PCRJournal of Clinical Microbiology, 2001
- Platelet-activating factor mediates acid-induced lung injury in genetically engineered miceJournal of Clinical Investigation, 1999
- Differing roles for platelet-activating factor during inflammation of the lung and subarachnoid space. The special case of Streptococcus pneumoniae.Journal of Clinical Investigation, 1992
- A Triazolodiazepine Platelet Activating Factor Receptor Antagonist (WEB 2086) Reduces Pulmonary Dysfunction During Endotoxin Shock in SwinePublished by Wolters Kluwer Health ,1991
- Modulation of Pulmonary Inflammation after Endotoxin Inhalation with a Platelet-Activating Factor Antagonist (48740 RP)International Archives of Allergy and Immunology, 1988